Skip to content
Support Us
Support Us
  • Contact us
St. Anna CCRI
  • Research
  • Institute
  • News
  • Careers
St. Anna CCRI
Support Us
Support Us
  • Groups
  • Institute
  • Working at St. Anna CCRI
  • Job Openings
  • News
  • Contact us
Back
  • Research Groups
  • Core Units & Platforms
  • Grants
  • Publications
  • Affiliated Clinicians
  • Reports
Back
  • Boztug Group
  • Cresswell Group
  • Dworzak Group
  • Grebien Group
  • Halbritter Group
  • Hutter Group
  • Kameneva Group
  • Kovar Group
  • Lion Group
  • Seruggia Group
  • Strehl Group
  • Taschner-Mandl Group
  • Tomazou Group
  • Christian Doppler Laboratory
  • Clinical Trials Unit | Attarbaschi
  • All Research Groups
Back
  • FACS Core Unit
  • Bioinformatics Core Unit
  • Innovative Cancer Models and ZANDR
Back
  • Research Management Office
  • National & International Grants
Back
  • Mission
  • History
  • Management
  • Administration
  • Science Communication, PR & Marketing
  • Funding
Back
  • Job Openings
  • Working at St. Anna CCRI
  • Recruiting and Onboarding
Back
  • Mission
  • History
  • Management
  • Administration
  • Science Communication, PR & Marketing
  • Funding

News

Decoding the epigenome and its regulation in neuroblastoma

Somatic Sex – the development of malignant diseases reinterpreted

“Rare diseases are also an emergency!”

Executive board of Europe’s neuroblastoma network SIOPEN

EU Commissioner visits St. Anna

Kaan Boztug awarded the “Işil Berat Barlan Award”

Bone marrow metastases for the first time analyzed cell by cell

Four FWF Stand Alone Projects recently approved at St. Anna CCRI

Study identifies better tolerable chemotherapy without loss of efficacy

A new language for congenital immune disorders

“1000 Ideas” to boost childhood cancer research

a new role for histone modifications in genomic imprinting

Gene defect shortens survival and needs targeted treatment

WWTF grant to promote precision medicine in childhood cancer

St. Anna Children’s Cancer Research Institute is receiving a prestigious Life Science Grant for Precision Medicine, provided by the Vienna Science and Technology Fund (WWTF). Award winner Eleni Tomazou and her colleagues will clinically validate a promising new diagnostic approach, expected to enable precision medicine in childhood tumors based on blood samples.

Blood test detects childhood tumors based on their epigenetic profiles

Invasive virus infections during chemotherapy: an underestimated factor

Beitrags-Navigation

« Previous 1 … 9 10 11 Next »

An error has occurred. Please try again later.
Thank you for signing up for our newsletter. We've emailed you a confirmation link.
Newsletter

Subscribe to our newsletter and stay up to date with our research.

St. Anna Kinderkrebsforschung GmbH
Zimmermannplatz 10
1090 Vienna 
Austria

T: +43 1 40470 0
F: +43 1 40470 7150

  • About
  • Labdia
  • Kinderkrebsforschung
  • Privacy Policy
  • Whistleblowing
  • Imprint

FOLLOW US:

  • Facebook
  • YouTube
  • Twitter
  • LinkedIn
  • Instagram

© 2026 St. Anna CCRI

To change your privacy setting, e.g. granting or withdrawing consent, click here: Settings